Johnson & Johnson Innovation – JJDC
Corporate VCInvestment thesis
Johnson & Johnson Innovation focuses on identifying and cultivating promising life science and healthcare innovations regardless of origin. The organization leverages its substantial internal expertise and resources to partner with external innovators across early-stage, incubation, venture, and late-stage development phases to advance breakthroughs that address global health challenges.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 3 of 3 portfolio companiesAI & Machine Learning ×2Healthtech ×2Biotech ×1Crypto & Web3 ×1Data & Infrastructure ×1Digital Health ×1Medical Devices ×1
HQs:United States×1
Investments · 3 tracked
founders shown can be your intro pathARO Network is an edge network infrastructure platform designed for AI agents to operate on local devices and residential networks using users' real-world resources. The platform enables individual users to earn cryptocurrency rewards by running nodes that provide computational power and bandwidth to support distributed AI agents.
AI & Machine LearningCrypto & Web3Data & Infrastructure
Fusion Pharma develops targeted alpha therapeutics for cancer treatment using proprietary linker technology to connect alpha-emitting medical isotopes to cancer-targeting molecules, delivering lethal damage to tumor cells while minimizing toxicity to healthy tissues.
BiotechHealthtechMedical Devices
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions. The company serves healthcare providers, health plans, and patients seeking evidence-based, technology-enabled chronic care management.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Kevin McRaith(President and CEO)Anand Iyer(Chief AI Officer)
Frequently asked questions
- What sectors does Johnson & Johnson Innovation – JJDC focus on?
- Johnson & Johnson Innovation – JJDC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.